Cargando…
Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3
The low regeneration potential of the central nervous system (CNS) represents a challenge for the development of new therapeutic strategies for neurodegenerative diseases, including spinocerebellar ataxias. Spinocerebellar ataxia type 3 (SCA3)—or Machado–Joseph disease (MJD)—is the most common domin...
Autores principales: | Correia, Joana Sofia, Neves-Carvalho, Andreia, Mendes-Pinheiro, Bárbara, Pires, Joel, Teixeira, Fábio Gabriel, Lima, Rui, Monteiro, Susana, Silva, Nuno André, Soares-Cunha, Carina, Serra, Sofia Cravino, Duarte-Silva, Sara, Teixeira-Castro, Andreia, Salgado, António José, Maciel, Patrícia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698556/ https://www.ncbi.nlm.nih.gov/pubmed/34944570 http://dx.doi.org/10.3390/biomedicines9121754 |
Ejemplares similares
-
Cell-based therapeutic strategies for treatment of spinocerebellar ataxias: an update
por: Correia, Joana Sofia, et al.
Publicado: (2022) -
Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP(3)R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3
por: Cunha-Garcia, Daniela, et al.
Publicado: (2023) -
Cerebellar neuronal dysfunction accompanies early motor symptoms in spinocerebellar ataxia type 3
por: Mayoral-Palarz, Kristin, et al.
Publicado: (2022) -
Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease
por: Esteves, Sofia, et al.
Publicado: (2015) -
Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2
por: Reetz, Kathrin, et al.
Publicado: (2018)